4 курс / Общая токсикология (доп.) / Медицинские_аспекты_противодействия_наркозависимости_в_Республике

296

310.Bush P.J., Iannotti R.J. Elementary schoolchildren’s use of alcohol, cigarettes and marijuana and classmates’ attribution of socialization // Drug-Alcohol-Depend, 1992 Aug. 30(3). - 275-87

311.Caplehorn J.R, McNeil D.R., Kleinbaum D.G. Clinic policy and retention in methadone maintenance. // Int J Addict. - 1993. - Vol. 28, № 1. - P. 7389

312.Caplehorn J.R., Dalton M.S., Haldar F., Petrenas A.M., Nisbet J.G. Methadone maintenance and addicts' risk of fatal heroin overdose. // Subst Use Misuse. - 1996. - Vol. 31. - P. 177-196.

313.Caplehorn J.R., Irwig L., Saunders J.B. Physicians' attitudes and retention of patients in their methadone maintenance programs. // Substance Use and Misuse. – 1996.

314.Caplehorn JR, McNeil DR, Kleinbaum DG. Clinic policy and retention in methadone maintenance. // Int J Addict. - 1993. - Vol. 28, № 1. - P. 73-89

315.Carroll K.M. Relapse prevention as a psychosocial treatment approach: areview of controlled clinical trials // Experimental and Clinical psychopharmacology. 1996, N 4. - Р. 46-54

316.Colbach E.M., Grove R.E. Marihuana Psychoses Associated in VietNam. Milit. Med., 1970, Stuttgart, Thieme, 1958

317.Condelli W.S. Strategies for increasing retention in methadone programs. J Psychoactive Drugs. - 1999. - Vol. 25, № 2.- P. 143-147.

318.Cooke C.H. “The Minnesota model in the management of drug and alcohol dependency: miracle, method, or myth? Part II: Evidence and conclusions”, British Journal of Addiction, No. 86, 1988, pp. 735-748.

319.Copeland J. A randomized controlled trial of brief cognitive-behavioral intervention for cannabis use disorder // Journal of Substance Abuse Treatment. 2001, N 21. - Р. 55-64

320.Copeland J. A randomized controlled trial of brief interventions for cannabis problems among young offenders // Drug and Alcohol Dependence. 2001, Vol. 63, supplement 1, 32 p.

321.Crits Christph Р. Psychosocial treatments for cocaine dependence: results from the NIDA collaborative cocaine treatment study // Archives of General Psychiatry. 1999, N 56. - Р. 493-502

322.De Leon G. and N.Jainchill “Male and female drug abusers: social and psychological status two years after treatment in a therapeutic community”, American Journal of Drug and Alcohol Abuse, No. 8, 1982, pp. 465-497.

323.De Leon G. and others, “Therapeutic community dropouts: criminal behaviour five years after treatment”, American Journal of Drug and Alcohol Abuse, No. 6, 1979, pp. 253-271.

324.De Leon G. Therapeutic Communities. - In: Textbook of Substance

Abuse Treatment // Ed by Mars Calanter M.P., Herbert D., Kleber M.D. – The American Psychiatric Press, 2nd Edition. – 1999. Washington

297

325.De Leon G., Wexler H.K. and Jainchill N. “The therapeutic community: success and improvement rates 5 years after treatment”, International Journal of Addiction, No. 17, 1982, pp. 703-747.

326.De Vries M.W., Kaplan Ch. D., Derks J.T.M. Psychiatric diagnosis in addiction treatment experiments // Lancet, 1997. № 9052. – P. 655-656

327.DeLeon G. Therapeutic Communities / In: Textbook of substance Abuse

Treatment / Ed. By Marc Galanter, M.D.Herbert D., Klefer, M.D. The American Psychiatric Press, 2nd Edition. 1999, Washington

328.Dennis M.L., Karuntzos G.T. and Rachal J.V., “Reaching community resources through case management to meet the needs of methadone clients”, Progress and Issues in Case Management, R. Asbury, ed., Research Monograph 127 (Rockville, Maryland, National Institute on Drug Abuse, 1992).

329.Dettmer K., Saunders B., Strang J. Прием налоксона в домашних условиях и предотвращение смертельных исходов вследствие передозировки опиатов: две пробные схемы // Обзор современной психиатрии. – 2002. – Вып. 4. – с. 56-57

330.Dinges N.G. Dnong -Tran Quang. Stressful life events and co–occuring depression, substance abuse and suicidality among Indian and Alaska native adolescents // Cult., med. and Psychiat., 1993. 16, № 4.- P. 487502

331.Dole V.P., Nyswander M.E. Addiction - A Metabolic Disease. // Arch Intern Med. 1967. - Vol. 120, № l.-P. 19-24

332.Dunn Y., Fahy T.A. Police admis-sions to a psychiatric hospital. Demographic and clinical differences between ethnic groups // Br. Y. Psychiatry, 1990. Mar. 156. - P. 373 – 378

333.Edwards G. Cross–national differences in measures of psychiatric morbidity // Mental health and society. - Vol. 4. № 3-4. 1979. – P. 126135

334.Empfehlungen zur Anwendung von Buprenorphin in der Substitutionsbehandlung opiatab-hangiger Patienten in der Schweiz, Osterreich und Deutschland. // Suchtmedizin in Forschung und Praxis. - 2000. - Vol 2, N. 1. - P. 43 - 53

335.European Monitoring Centre for Drugs and Drug Addiction (1997). Annual of the State of the Drugs Problem in the European Union, 1997. Lisbon: EMCDDA

336.Farre M., Mas A., Torrens M., Moreno V., Cami J. Retention rate and illicit opioid use during methadone maintenance interventions: a metaanalysis. // Drug and Alcohol Dependence. - 2002. -Vol.65.-P. 283-290

337.Fejer D., Smart R.G. The knowledge about drugs, attitudes towards them and drug use rates of high school students // J.Drug. Educ., 1973. Vol. 3. № 4.- P. 377-388

338.Fiorentine R. and Anglin M.D. Does increasing the opportunity for camselin increase the effectiveness of outpatient drug treatment? //

298

American Journal of Drag and Alcohol Abuse, Vol. 23, N 3, 1997. - Р. 369-382

339.Fischer G, Gombas W., Eder H., Jagsch R., Stuehlinger G., Aschauer H.N., Kasper S. Vergleichsuntersuchung von Buprenorphin und Methadon im Rahmen der Erhaltungstherapie Opiatkranker. // Nervenarzt. - 1999. - Vol. 70. - P. 795-802

340.Fisher D.G., Anglin M.D. Survival analysis in drug program evaluation. Part I. Overall program effectiveness. // Int J Addict. -1987.- Vol. 22, № 2.- P. 115-34

341.French M.T. and others, “Training and employment programs in methadone treatment: client needs and desires”, Journal of Substance Abuse Treatment, No. 9, 1992, pp. 293-303.

342.Giacomuzzi S.M., Riemer Y, Kemmler G., Ertl M., Richter R., Roessler H., Hinterhuber H. Sub-jektives Wohlbefinden und somatische Merkmale bei Methadonsubstitution. // Fortschritte der Medizin 2001.-Vol. 119.- P. 103-108.

343.Gibson D.R., Flynn N.M., McCarthy J.J. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. // AIDS. - 1999. - Vol. 13. - P. 1807-1818.

344.Goelz J. Der drogenabhaengige Patient. Urban & Fischer, 1999.

345.Gossop M. and others “The National Treatment Outcome Research Study in the United Kingdom: six-month follow-up outcomes”, Psychology of Addictive Behaviors, No. 11, 1997, pp. 324-337.

346.Gunne L.M, Gronbladh L. The Swedish methadone maintenance program: a controlled study. // Drug Alcohol Depend. - 1981. - Vol. 7. -

P.249-56

347.Hall G.W., Takushi R.Y., Carriero N.Y. Psychiatric comorbidity of cocainedependent outpatients; corretation with treatment outcome // Rockville (Md.), 1997. – P. 126

348.Halliday R. Management of the Narcotic addict. // British Columbia Medical Journal. - 1963. -P. 412-414

349.Hartland N., McDonald D. at.al. Australian reports into drug use and possibility of hero in maintenance // Drug and Alcohol Review, 1992. Vol. 2. № 2.- P. 175-182

350.Hartnoll R.L., Mitcheson M.C., Battersby A., Brown G., Ellis M., Fleming P., Hedley N. Evaluation of heroin maintenance in controlled trial. // Arch Gen Psychiatry. - 1980. - Vol. 37 - P. 877-884.

351.Hawkins J.D., Catalano R.F., Wells E.A. Measuring effect of skill training intervention for drug abusers // Journal of Consulting and Clinical Psychology. 1986, Vol. 54, N 4. - p. 661-664

352.Hesselbrock V.M., Segal B. Clinical profile of treated Alaskan Native problem drinkers // Abstr. Rec. Soc. Alcoholism Annual Sci. Meet., San Francisco, Calif., July 19-24, 1997. Alcoholism. 1997. 21, № 3, suppl. -

P.59A

299

353.Higgins S.T. and other Incentives improve outcome in outpatient behavioral treatment of cocaine dependence // Archives of General Psychiatry. 1994, N 51. - Р. 568-576

354.Higgins S.T. and other Outpatient behavioral treatment for cocaine dependence // Experimental and Clinical psychopharmacology. 1995, N 3. - Р. 205-212

355.Higgins S.T. and others, “A behavioral approach to achieving initial cocaine abstinence”, American Journal of Psychiatry, No. 148, 1991, pp. 1218-1224.

356.Horvath A.O. and Symonds B.D., “Relation between alliance and outcome in psychotherapy: a meta-analysis”, Journal of Counselling Psychology, No. 38, 1991, pp. 139-149.

357.Hubbard R.L. and other Overiew of 1 year outcome in the drug abuse treatment outcome study (DATOS) // Psychology of Addictive Behaviors. 1997, N 11, p. 261-278.

358.Hubbard R.L. and others, “Overview of 1-year outcomes in the drug abuse treatment outcome study (DATOS)”, Psychology of Addictive Behaviors, No. 11, 1997, pp. 261-278.

359.Hubbard R.L. and others, Drug Abuse Treatment: A National Study of Effectiveness (Chapel Hill, North Carolina, University of North Carolina Press, 1989).

360.Hughes P.H. Extent of drug abuse: an international review with implications for health planners // World Health Status, 1983. Vol. 36. № 3-4 (WHO-Geneva). – P. 36

361.Hughes P.H. Extent of drug abuse: an international review with implications for health planners // World Health Status, 1983. Vol. 36. № 3-4 (WHO-Geneva). – P. 36

362.Hunnekens H. Drogengefahrung unserez Jugend // Offent Gemundhheitwesen, 1986. Bd. 48. № 8. – P. 404-407

363.Johnson R.E., Chutuape M.A., Strain E.C., Walsh S.L., Stitzer M.L., Bigelow G.E. A comparison of levomethadyl acetate, buprenorphine, and methadobe for opioid dependence. // N Engi J Med. - 2000.- Vol. 343. - P. 1290-1297

364.Johnson R.E., Jaffe J.H., Fudala P.J. A controlled trial of buprenorphine treatment for opioid dependence. // JAMA. - 1992. - Vol. 267. - P. 27502755.

365.Kahn M.W., Hannah M., Kirkland S., Lesink S., Clemens C., Chatel D. Substances misuse, emotional disturbance, and dual diagnosis in a mealline population of mixed ethnicity // Int. J. Addict, 1992. Mar. 27(3).- P. 317-330

366.Kandel D.B. Drogengefahrung unserer Jugend // Offent Gemyndheitwesen, 1986. Bd. 48. № 8. – P. 404-407

367.Kang S.Y., De Leon. Correlates of drug injection behavior among methadobe outpatients. Am J Drug Alcohol Abuse.-1993.-Vol. 19.- P. 107-118

300

368.Kaplan H.S. Psychosis associated with marihuana // N-Y. St.J. Med., 1971. № 4.- P. 15-19

369.Kawakami F., Fujimura K., Fukui K., Iwashege T., Nakajima T. Влияние гидрохлорида миансерина на депрессию, вызванную хроническим алкоголизмом // Антидепрессанты в терапии патологического влечения к психоактивным веществам. – Москва, 1998. – С. 57-62

370.Kendler K.S, Gardner Ch.O., Prescott C.A. Religion, psychopathology, and substance use and abuse: A multimeasure, genetic-epidemiologic study // Amer. Y.Pcychiat., 1997. – 154. № 3. – P. 322 - 329

371.Kirby K.C. Schedule of voucher delivery influences initiation of cocaine abstinence // Journal of Consulting and Clinical Psychology. 1998, Vol. 66, N 5. - Р. 761-767

372.Kosten T.R., Rounsaville B.Y., Kleber H.D. Relationship of depression toclonidine detoxification of opiate addiets // Compr. Psychiat, 1984, Vol. 25, № 5. - P. 503-508

373.Kosten T.R., Schottenfeld R., Ziedonis D., Falcioni J., Buprenorphine versus methadone maintenance for opioid dependence. // J. Nerv. Ment. Dis. - 1993. - Vol. 181. - P. 358-364.

374.Krausz M., Naber D., Raschke P., Flenker U. Heroin als Medikament. // Deutsches Aerzte-blatt. - 2002. - Vol. 99. - P. 26

375.Krausz M., Raschke P., Naber D. Substitution von Heroinabhangigen mit Methadon. // Internist. - 1999. - Vol. 40. - P. 645-650

376.Legal aspects of substitution treatment. An insight into nine EU countries. EMCDDA, 2003

377.Lehman F., Lauzon P., Amsel R. Methadone maintenance: predictors of outcome in a Canadian milieu. // J Subst Abuse Treat. - 1993. - Vol. 10.- P. 85-89.

378.Ling W., Wesson D.R., Charuvastra C., Klett C.J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. // Arch. Gen. Psychiat. - 1996. - Vol. 53. - P. 401-407

379.Lintzeris N., Clark N., Muhleisen P., Ritter A., Ali R, Bell J, Gowing L, Hawkin L, Henry Edwards S., Mattick R.P., Monheit В., Newton I., Quigley A., Whicker S., White J. National Clinical Guidelines and Procedures for the use of Buprenorphine in the Treatment of Heroin Dependence. Department of Health and Aged Care, 2001

380.Lovejoy M. and others, “Patients' perspectives on the process of change in substance abuse treatment”, Journal of Substance Abuse Treatment, No. 12, 1995, pp. 269-282.

381.MacDonald D.L. Patterns of alcohol drug abuse and mental health administration // Y.Amer. med. ASS, 1986. Vol. 256. № 23.- 3201 p.

382.Magura S., Rosenblum A. Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored. // Mount Sinai Journal of Medicine. - 2001. - Vol. 68, №1. - P. 62-74

301

383.Mande-Griffin Р.М. Superior efficacy of cognitive – behavioral therapy for urban crack cocaine abusers: main and matching effects // Journal of Consulting and Clinical Psychology. 1998, Vol. 66, N 5. - Р. 832-837

384.Mattick R.P., Ali R., White J.M., O'Brien S., Wolk S., Danz C. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. // Addiction. - 2003, 441-452

385.McElrath К. Review of Research on Substitute Prescribing for Opiate Dependence and Implications for Northern Ireland, 2003. Unpublished report

386.McKay J.R. et. all. Group counseling vs. individualized relapse prevention aftercare following intensive outpatient treatment for cocaine dependence: initial results // Journal of Consulting and Clinical Psychology. 1997, N 65. - Р. 778-788

387.McLellan A.T. and others, “Similarity of outcome predictors across opiate, cocaine and alcohol treatments: role of treatment services”, Journal of Consulting and Clinical Psychology , vol. 62, No. 6 (1994), pp. 1141-1158.

388.McLellan A.T., Arndt I.О., Metzger D.S., Woody G.E., O'Brien C.P. The effects of psycho-social services in substance abuse treatment. // JAMA. - 1993. - Vol. 269. - P. 1953-1959.

389.Mennesinger M. Lesguels finiront toxicomanes // Sci. et. via., 1991. № 883. – P. 42-56

390.Miller N.S. Drug testing: Medical, legal and latilac issues // Y.Subst. Abuse Freat. – 1990. № 4. – P. 239-244

391.Miller W., Rollnick S. Motivational interviewing: preparing people to change addictive behavior. New York, Guildford Press, 1991

392.Miller W.R. Motivation Enhancement Therapy: Description of Counseling Approach // Approaches to drug Abuse Counseling. NIDA. Rockville, 2000. - Р. 99-106

393.Monti P.M. Brief coping skills treatment for cocaine abuse: substance use outcomes at three months // Addiction. Vol. 92, N 12, 1997. - Р. 17171728

394.Najavits L.M. and Weiss R.D. “Variations in therapist effectiveness in the treatment of patients with substance use disorders: an empirical review”, Addiction, vol. 89, No. 6 (1994), pp. 679-688.

395.NIDA: тринадцать принципов эффективного лечения наркомании // Вопросы наркологии, - 2000. № 1. - С. 29-30

396.O'Connor P.G., Oliveto A.H., Shi J.M., Triffleman E.G., Carroll K.M., Kosten T.R., Rounsaville B.J., Pakes J.A., Schottenfeld R.S. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. // Am J Med. - 1998. - Vol. 105. -P. 100-105.

302

397.Paulus I., Halliday R. Rehabilitation and the Narcotic Addict: Results of a comparative methadone withdrawal program. // Canadian Medical Association Journal. - 1967. - Vol. 96. - P. 655-659

398.Perneger T.V., Mino A., Giner P., Broers B. Patterns of opiate use in a heroin maintenance programme. // Psychopharmacology - 2000. - Vol.

152.- P. 7-13

399.Pernerger T.V., Giner F.S., del Rio M., Mino A. Randomized trial of heroin maintenance programme for addicts who fail in conventional drug treatments. // Br. Med. J. - 1998. - Vol. 317. - P. 13-18.

400.Petitjean S., Stohler R., Deglon J.J., Levoti S., Waldvogel D., Uehlinger C., Ladewig D. Double-blind randomized trial of buprenorphine and methadone in opiate dependence. // Drug and Alcohol Dependence. - 2001. - Vol. 62. -P. 97-104

401.Platt J.J. “Vocational rehabilitation of drug abusers”, Psychological Bulletin, No. 117, 1995, pp. 416-435.

402.Platt J.J., Metzger D.S. Cognitive interpersonal problem solving skills and the maintenance of treatment success in heroin // Psychology of Addictive Behaviors. 1987, N 1. - Р. 5-13

403.Poshyachinda V. Future outlook of drug dependence in Thailand Reported at the 11th Word Conference of Therapeutic Communities. - Bangkok, 1988. – P. 1-20

404.Rehn N., Room R., Edwards G. Алкоголь в Европейском регионе. ВОЗ - потребление, вред и политика // Всемирная организация здравоохранения. – Европейское региональное бюро, 2001

405.Report by Pompidou Group // DRSTR, - London. NMSO, 1998

406.Report on the drug situation in the candidate CEECs. Luxembourg: Office for Official Publications of the European Communities, 2002

407.Ryan T.M., Booth M.W., Yih-Ing Nser //The International Journal of Adoliction, 1988. Vol. 23. – P. 125-149

408.Ryan T.M., Booth M.W., Yih-Ing Nser //The International Journal of Adoliction, 1988. Vol. 23. – P. 125-149

409.Scherbaum N., Beckmann J.P., Klein S, Rehm J. Medizinethische Aspekte der arztlichen Hero-inverschreibung. //Nervenarzt. - 2001. - Vol.

72.-P. 717-722.

410.Schottenfeld R.S., Pakes J.R., Oliveto A., Ziedonis D., Kosten T.R. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. // Archs. Gen. Psychiat. - 1997. - Vol. 54. -P. 713-720

411.Senay B.C. Drag abuse and Public Health. A Global perspective. Drug Saferty. Supplement, 1991. Vol. 6.- P. 1-65

412.Seoane A., Carrasco G., Cabre L., Puiggros A., Hernandez E., Alvarez M, Costa J, Molina R, Sobrepere G Эффективность и безопасность двух новых методов быстрой внутривенной детоксикации у пациентов с героиновой наркоманией, безуспешно лечившихся ранее // Обзор современной психиатрии. – 1999. – Вып. 3. – с. 77-84

303

413.Shaffer H.J., LaSalvia T.A., Stein J.P. Comparing Hatha yoga with dynamic group psychotherapy for enhancing methadone maintenance treatment: a randomized clinical trial. Altern Ther Health Med. - 1997. - Vol. 3. - P. 57-66.

414.Simpson D.D. and others, “Client engagement and change during drug abuse treatment”, Journal of Substance Abuse, No. 7, 1995, pp. 117-134.

415.Simpson D.D., Joe G.W. and Lehman W.E.K. “Addiction careers: summary of studies based on the DARP 12-year follow-up”, NIDA Treatment Research Report, DHHS publication No. AMD 86-1420 (Rockville, Maryland, National Institute on Drug Abuse, 1986).

416.Smart R.G., Murray G.F., Arif A.N. Drug Abuse and Prevention Programs in 29 Countries // Int. J. Addict, 1988. Vol. 23. № 1. – P. 1-17

417.Solberg U., Burkhart G., Nilson M. An overview of opiate substitution treatment in the European Union and Norway. // International Journal of Drug Policy. - 2002. - Vol. 13. -P. 477484

418.Sontag H. Клиническое исследование влияния миансерина на алкогольную депрессию, возникающую после детоксикации // Антидепрессанты в терапии патологического влечения к психоактивным веществам. – Москва, 1998. – С. 63-69

419.Soulif M., Yunis F., Taha H. Extend and patterns of drug abuse in France and Europe, 1986, Ibid.- P.113-121

420.Steffen Th., Uchtenhagen A., Gutzwiller F., Dobler-Mikola A., Blattler R.,PROVE Team. Die heroingestutzte Behandlung von Opiatabhangigen.

//Internist. - 1999. - Vol. 40. - P. 651-656

421.Steffen Th., Uchtenhagen A., Gutzwiller F., Dobler-Mikola A., Blatter R., PROVE Team. Die heroingestutzte Behandlung von Opiatabhangigen // Internist. – 1999. – Vol. 40. – P. 651-656

422.Stephens R.S., Roffman R.A., Curtin L. Compasion of extended versus brief treatments for marijuana use // Journal of Consulting and Clinical Psychology. 2000, N 68. - Р. 898-908

423.Stephens R.S., Roffman R.A., Simpson E.E. Treating adult marijuana dependence: a test the relapse prevention model // Journal of Consulting and Clinical Psychology. 1994, N 62. - Р. 92-99

424.Strain E.C., Stitzer M.L., Liebson I.A, Bigelow G.E.. Methadone dose and treatment outcome. // Drug Alcohol. Depend. - 1993. - Vol. 33. -P. 105-117

425.Strain E.C., Stitzer M.L., Liebson I.A., Bigelow G.E. Buprenorphine versus methadone in the treatment ofopioid-dependent cocaine users. // Psychopharmacology. - 1994. - Vol. 116. - P. 401-406

426.Tchronicker W. Narcotica – legal Suchtreport, 1992. № 1. – P. 48-51

427.Thornton W.E., Thornton B.P. Narcotic poisoning: a review of literature

//Am.J.Psychiatry, 1974. Vol. 131. № 8. - P. 867-869

428.Torrens M., San L., Martinez A., Castillo C., Domingo-Salvany A., Alonso J. Use of the Nottingham Health Profile for measuring health

304

status of patients in methadone maintenance treatment. // Addiction. - 1997. - Vol. 92, № 6. - P. 707-16.

429.Ullmann R. Geschichte der arztlichen Verordnung von Opioiden an Abhaengige. // Suchtthera-pie 2001.-№2.-P. 20-27

430.United Nations Office for Drag Control and Crime Prevention. Countries profile on Drugs and Crime, 2002

431.Van Beusekom I., Iguchi M.Y. A review of recent advances in knowledge about methadone maintenance treatment. RAND Europe, 2001

432.Van den Brink W., Hendriks V.M., Van Ree J.M. Artzliche Verschreibung von Heroin an chronische, therapieresistente Methadonpatienten in den Niederlanden. // Suchttherapie. 2000, Vol. 1. P. 71-82.

433.Ward J., Hall W., Mattick R.P. Role of maintenance treatment in opioid dependence. // Lancet. 1999.-Vol. 353. -P.221-26

434.Westermeyer J. Sex differences in drug and alcohol use among ethnic groups in Laos, 1965-1975 // Am-J-Drug-Alcohol-Abuse, 1988. 14(4).- 443-61

435.Whitaker B. The global connection: the crises of Drug addiction. – London, 1987. – 432 s.

436.WHO. European Summary on Drag Abuse. WHO, Regional office for Europe, 1992. – P. 94

437.Woody G.E. Psychiatric severity as a predictor of benefits from psychotherapy // American journal of Psychiatry. Vol. 141, N 10, 1984. - Р. 1171-1177

438.World drink trends 1999. Henley on Themes, NTC Publications, 1999